RHYTHM PHARMACEUTICALS, INC. — Director's Dealing 2022

Jun 10, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RHYTHM PHARMACEUTICALS, INC. (RYTM)
CIK: 0001649904
Period of Report: 2022-06-08

Reporting Person: MCGIRR DAVID W J (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-06-08	Stock Option (right to buy)	$4.15	A	20000	Acquired	2032-06-07	Common Stock (20000)	Direct

Footnotes

F1: The options fully vest upon the earlier of (i) June 8, 2023 or (ii) the date of the Issuer's next annual meeting of the stockholders.